Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains Difficult
Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains Difficult …C0NTINUE READING HERE>>> Semaglutide has been approved by the Food and Drug Administration (FDA) for type 2 diabetes management, weight loss, and heart disease prevention. About 137 million Americans—more than half of all adults—are eligible for this drug based on … Read more